Market Overview:
The global etanercept market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of autoimmune diseases, increasing awareness about etanercept therapies, and growing demand for biosimilars. However, patent expirations of key products and stringent regulatory requirements are some of the major factors restraining the growth of this market. The global etanercept market is segmented on the basis of type, application, and region. On the basis of type, it is divided into benepali (sold under brand name Benepali), enbrel (sold under brand name Enbrel), and others (including adalimumab [sold under brand name Humira], golimumab [sold under brand name Simponi], certolizumab pegol [sold under brand name Cimzia]). On the basis of application, it is classified into arthritis (including rheumatoid arthritis and psoriatic arthritis), psoriasis vulgaris/plaque psoriasis), spondylitis ankylosing spondylitis)}, ileitis Crohn's disease}, uveitis juvenile idiopathic}. Geographically, it is analyzed across North America,, Europe,, Asia Pacific}.,and Middle East & Africa}.
Product Definition:
Etanercept is a recombinant human TNF receptor molecule. Etanercept is used in the treatment of autoimmune diseases, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease.
Benepali:
Benepali is a new name in the etanercept market. It's an off-label drug used for the treatment of chronic pruritus associated with psoriasis. The U.S.
Enbrel:
Enbrel is a prescription medicine used to treat arthritis, plaque psoriasis and Crohn's disease. It works by modifying the immune system to stop inflammation. The medicine was developed by recombinant DNA technology as a joint venture between Eli Lilly & Company and Pfizer Inc. in the early 1990s.
Application Insights:
Psoriasis was the most prominent application segment in 2017 and accounted for over 30% of total revenue. Psoriasis is a chronic disease which may result in severe skin damage and impairment of quality of life. Etanercept offers clinical benefits in treating psoriasis as it reduces inflammation along with the associated symptoms such as scaliness, itching and redness. The rising prevalence of psoriasis coupled with growing awareness about etanercept as an effective treatment option is expected to boost market growth during the forecast period.
Arthritis held a significant share owing to increasing incidence rates, high unmet medical needs, changing lifestyles & demographic trends among others. As per WHO estimates, around 54 million people worldwide suffer from arthritis while 1 billion have been diagnosed with the condition globally making it one of the leading causesof disability across all age groups globally speaking affecting both young & old people alike!.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of patients suffering from autoimmune diseases and high awareness levels coupled. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to increasing R&D investments by major companies, rising healthcare expenditure, and growing adoption of new technologies such as biosimilars.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to factors such as improving economic conditions, expanding population base with rising disposable income levels, and rise in consumer awareness regarding treatment options for chronic disorders. Moreover, government initiatives for improving healthcare infrastructure are also likely boost regional market growth over the next eight years or so.
Growth Factors:
- Increasing incidence of autoimmune diseases: The global prevalence of autoimmune diseases is increasing at an alarming rate. This is primarily attributed to the changing lifestyles and environmental factors. Etanercept is one of the most effective drugs for treating various autoimmune diseases and its demand is expected to rise in the coming years.
- Growing awareness about etanercept therapy: There is a growing awareness among physicians and patients about the benefits of etanercept therapy for treating various autoimmune diseases. This is likely to boost the demand for etanercept in the coming years.
- Rising number of clinical trials on etanercept: A large number of clinical trials are being conducted on etanercept across the globe, which reflects its growing popularity as a treatment option for various autoimmune diseases. This will further fuel the growth of Etanercept market in future..
Scope Of The Report
Report Attributes
Report Details
Report Title
Etanercept Market Research Report
By Type
Benepali, Enbrel, Others
By Application
Arthritis, Psoriasis, Spondylitis, Others
By Companies
Amgen, Pfizer, Takeda, Sanofi, GlaxoSmithKline, Sandoz, Celltrion, Dexa Medica, Bionovis, Momenta Pharmaceuticals, Amgen, MedImmune, Tsumura
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Etanercept Market Report Segments:
The global Etanercept market is segmented on the basis of:
Types
Benepali, Enbrel, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Arthritis, Psoriasis, Spondylitis, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amgen
- Pfizer
- Takeda
- Sanofi
- GlaxoSmithKline
- Sandoz
- Celltrion
- Dexa Medica
- Bionovis
- Momenta Pharmaceuticals
- Amgen
- MedImmune
- Tsumura
Highlights of The Etanercept Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Benepali
- Enbrel
- Others
- By Application:
- Arthritis
- Psoriasis
- Spondylitis
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Etanercept Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Etanercept is a medication used to treat rheumatoid arthritis. It works by blocking the activity of certain proteins in the body that are responsible for inflammation.
Some of the major companies in the etanercept market are Amgen, Pfizer, Takeda, Sanofi, GlaxoSmithKline, Sandoz, Celltrion, Dexa Medica, Bionovis, Momenta Pharmaceuticals, Amgen, MedImmune, Tsumura.
The etanercept market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Etanercept Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Etanercept Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Etanercept Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Etanercept Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Etanercept Market Size & Forecast, 2020-2028
4.5.1 Etanercept Market Size and Y-o-Y Growth
4.5.2 Etanercept Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Benepali
5.2.2 Enbrel
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Arthritis
6.2.2 Psoriasis
6.2.3 Spondylitis
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Etanercept Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Etanercept Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Benepali
9.6.2 Enbrel
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Arthritis
9.10.2 Psoriasis
9.10.3 Spondylitis
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Benepali
10.6.2 Enbrel
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Arthritis
10.10.2 Psoriasis
10.10.3 Spondylitis
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Benepali
11.6.2 Enbrel
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Arthritis
11.10.2 Psoriasis
11.10.3 Spondylitis
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Benepali
12.6.2 Enbrel
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Arthritis
12.10.2 Psoriasis
12.10.3 Spondylitis
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Benepali
13.6.2 Enbrel
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Arthritis
13.10.2 Psoriasis
13.10.3 Spondylitis
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Etanercept Market: Competitive Dashboard
14.2 Global Etanercept Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Amgen
14.3.2 Pfizer
14.3.3 Takeda
14.3.4 Sanofi
14.3.5 GlaxoSmithKline
14.3.6 Sandoz
14.3.7 Celltrion
14.3.8 Dexa Medica
14.3.9 Bionovis
14.3.10 Momenta Pharmaceuticals
14.3.11 Amgen
14.3.12 MedImmune
14.3.13 Tsumura
